Cabinet approves Rs 9,589 cr FDI in Suven Pharmaceuticals by Cyprus-based firm https://ift.tt/uLVhwWI

On Wednesday, the government gave the go-ahead for Cyprus-based Berhyanda Ltd.'s proposed foreign investment of up to Rs 9,589 crore in Suven Pharmaceuticals. An official statement following the meeting of the Cabinet Committee on Economic Affairs stated that the approval is for Berhyanda to purchase up to 76.1% of the outstanding shares of Suven Pharmaceuticals through the transfer of shares from current promoter shareholders and public shareholders through a mandatory open offer.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/x2cRXEq